Adenoma clinical trials

The registry lists 182 studies for Adenoma across more than 10 countries. 28 are recruiting or about to start. 66 of them are mainly about Adenoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Mesothelioma, Malignant: 1,088 studies, 214 open.

Get an email when these change. Save the Adenoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 92
Status unknown: 40
Recruiting: 16
Terminated: 10
Not yet recruiting: 10
Active, not recruiting: 8

Phase

Phase 3: 13
Phase 2: 10
Phase 4: 4
Phase 1: 2
Early Phase 1: 1

Where

United States: 50
China: 35
Germany: 20
United Kingdom: 14
France: 11
Netherlands: 8

Who runs them

Air Force Military Medical University, China (7) · Smart Medical Systems Ltd. (7) · Changhai Hospital (7) · Western Sydney Local Health District (5) · London North West Healthcare NHS Trust (5) · Technical University of Munich (4) · Assistance Publique - Hôpitaux de Paris (3) · Sorlandet Hospital HF (3)

What is being tested here

Drugs under test in Adenoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
S-Adenosylmethionine	1	0	1
68Ga-pentixafor	1	0	1
Aspirin	0	2	2
Folic Acid	0	1	2
Sunitinib	0	0	2
Calcium Carbonate	0	2	2
Ursodeoxycholic Acid	0	2	2
Cabergoline	0	1	1
Polyethylene Glycols	0	0	1
Cholecalciferol	0	1	1

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3

Coming up

2phase 3 studies under way

12studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas · Phase 3 · St. Olavs Hospital
Dec 2026AI in Predicting Polyp Pathology and Endoscopic Classification · Peking Union Medical College Hospital
Dec 2026Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions · WAYCEN Inc
Dec 2026Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions · Instituto do Cancer do Estado de São Paulo
Dec 2026Comparison of Adenoma Detection Rate in 3D vs. 2D Surveillance Colonoscopy · National Taiwan University Hospital
Dec 2026Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC) · Zhejiang University
Jan 2027Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Colorectal Laterally Spreading Lesions. · José Carlos Marín Gabriel
Jan 2027Evaluation of Versatile Intelligent Staining Technology (VIST) and Spectral Flexible Imaging (SFI) for Detection and Optical Characterization of Colorectal Lesions: A Prospective Randomized Controlled Study · Alexandre Vontobel Padoin
Feb 2027Recurrence After Gastric and Intestinal Polyp Resection · LanZhou University
Aug 2027Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma · GCS Ramsay Santé pour l'Enseignement et la Recherche

Who these studies take

Of the 16 Adenoma studies recruiting now, 11 (69%) set no upper age limit and 1 (6%) stop at 75 or younger. 1 (6%) take children under 18. 0 (0%) are for women only and 1 (6%) for men only; 6 (38%) take healthy volunteers.

Recruiting studies that take each age, of 16
Age	Women	Men
10	1 (6%)	1 (6%)
18	12 (75%)	12 (75%)
30	12 (75%)	12 (75%)
40	15 (94%)	15 (94%)
50	15 (94%)	16 (100%)
65	15 (94%)	16 (100%)
75	14 (88%)	15 (94%)
85	12 (75%)	13 (81%)

Across all 182 studies, recruiting or not: 25% stop at 75 or younger and 4% at 65; 8% take children; 1% are for women only and 2% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Adenoma studies take

Of 50 interventional studies with no phase under Adenoma, half reached primary completion within 34 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	34 mo19–50 · 50 studies	—	37 mo19–50 · 44 studies
Observational	45 mo14–103 · 22 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® RegistryOct 28, 2026NCT07142902

Newly registered1

Protein Signature Based Screening of Colorectal Adenomas and CancerOct 19, 2026NCT07881549

Studies

Recruiting first, then most recently updated. Showing 50 of 182. Browse all 182 → or search them.